171 related articles for article (PubMed ID: 34719102)
1. Genetic analysis of single disseminated tumor cells in the lymph nodes and bone marrow of patients with head and neck squamous cell carcinoma.
Sproll KC; Schorn LK; Reising B; Schumacher S; Lommen J; Kübler NR; Knoefel WT; Beier M; Neves RP; Behrens B; Horny K; Stoecklein NH
Mol Oncol; 2022 Jan; 16(2):333-346. PubMed ID: 34719102
[TBL] [Abstract][Full Text] [Related]
2. Disseminated tumour cells with highly aberrant genomes are linked to poor prognosis in operable oesophageal adenocarcinoma.
Schumacher S; Bartenhagen C; Hoffmann M; Will D; Fischer JC; Baldus SE; Vay C; Fluegen G; Dizdar L; Vallböhmer D; Klein CA; Knoefel WT; Stoecklein NH; Möhlendick B
Br J Cancer; 2017 Aug; 117(5):725-733. PubMed ID: 28728164
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCC.
Sproll C; Freund AK; Hassel A; Hölbling M; Aust V; Storb SH; Handschel J; Teichmann C; Depprich R; Behrens B; Neves RP; Kübler NR; Kaiser P; Baldus SE; Tóth C; Kaisers W; Stoecklein NH
Int J Cancer; 2017 May; 140(9):2112-2124. PubMed ID: 28120418
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread.
Hartkopf AD; Banys M; Krawczyk N; Staebler A; Becker S; Hoffmann J; Hahn M; Wallwiener M; Fehm T
Breast Cancer Res Treat; 2012 Jan; 131(2):501-8. PubMed ID: 21971730
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of EpCAM-positive disseminated tumor cells in rectal cancer patients with stage I disease.
Dhayat S; Sorescu S; Vallböhmer D; Kraus S; Baldus SE; Rehders A; Kröpil F; Krieg A; Knoefel WT; Stoecklein NH
Am J Surg Pathol; 2012 Dec; 36(12):1809-16. PubMed ID: 23060348
[TBL] [Abstract][Full Text] [Related]
6. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
[TBL] [Abstract][Full Text] [Related]
7. Temporal and spatial characteristics of tumor evolution in a mouse model of oral squamous cell carcinoma.
Cao Y; Dong H; Li G; Wei H; Xie C; Tuo Y; Chen N; Yu D
BMC Cancer; 2022 Nov; 22(1):1209. PubMed ID: 36424557
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer.
Trivedi S; Mattos J; Gooding W; Godfrey TE; Ferris RL
Otolaryngol Head Neck Surg; 2013 Aug; 149(2):261-8. PubMed ID: 23625795
[TBL] [Abstract][Full Text] [Related]
11. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma.
Scherpelz KP; Wong AC; Lingen MW; Taxy JB; Cipriani NA
Histopathology; 2019 Jan; 74(2):321-331. PubMed ID: 30144145
[TBL] [Abstract][Full Text] [Related]
12. Eps8 expression is significantly lower in p16
Nasri E; Wiesen LB; Knapik JA; Fredenburg KM
Hum Pathol; 2018 Feb; 72():45-51. PubMed ID: 29107665
[TBL] [Abstract][Full Text] [Related]
13. Validation of markers for the screening and identification of disseminating tumor cells in lymph nodes and bone marrow.
Alexander M; Reising B; Schumacher S; Sproll C; Stoecklein NH
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):77-9. PubMed ID: 23260007
[No Abstract] [Full Text] [Related]
14. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
Conzelmann M; Dieterle CP; Linnemann U; Berger MR
Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
[TBL] [Abstract][Full Text] [Related]
16. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
Wimberger P; Heubner M; Otterbach F; Fehm T; Kimmig R; Kasimir-Bauer S
Gynecol Oncol; 2007 Nov; 107(2):331-8. PubMed ID: 17764727
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
[TBL] [Abstract][Full Text] [Related]
18. Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.
Dejaco D; Steinbichler T; Schartinger VH; Fischer N; Anegg M; Dudas J; Posch A; Widmann G; Riechelmann H
BMJ Open; 2019 Feb; 9(2):e025359. PubMed ID: 30782931
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice.
Brand M; Laban S; Theodoraki MN; Doescher J; Hoffmann TK; Schuler PJ; Brunner C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383676
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
Magbanua MJM; van 't Veer L; Clark AS; Chien AJ; Boughey JC; Han HS; Wallace A; Beckwith H; Liu MC; Yau C; Wileyto EP; Ordonez A; Solanki TI; Hsiao F; Lee JC; Basu A; Brown Swigart L; Perlmutter J; Delson AL; Bayne L; Deluca S; Yee SS; Carpenter EL; Esserman LJ; Park JW; Chodosh LA; DeMichele A
Breast Cancer Res Treat; 2023 Apr; 198(2):383-390. PubMed ID: 36689092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
